Messenger ribonucleic acid expression of 16 matrix metalloproteinases in bone-implant interface tissues of loose artificial hip joints

Journal of Biomedical Materials Research

Volumn 52, Issue 4, 2000, Pages 613-620

  Takei, Isao ^a   Takagi, Michiaki ^a   Santavirta, Seppo ^b   Ida, Hideo ^a   Ishii, Masaji ^c   Ogino, Toshihiko ^a   Ainola, Mari ^d   Konttinen, Yrjö T ^d  

^a YAMAGATA UNIVERSITY   (Japan)

^b UNIVERSITY OF HELSINKI   (Finland)

^c Saiseikai Yamagata Hospital   (Japan)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Matrix metalloproteinase (MMP); Messenger ribonucleic acid (mRNA); Osteolysis; Prosthetic loosening; Total hip arthroplasty

Indexed keywords

BIODEGRADATION; BONE; IMPLANTS (SURGICAL); INTERFACES (MATERIALS); RNA;

MATRIX METALLOPROTEINASES; OSTEOLYSIS; PROSTHETIC LOOSENING;

HIP PROSTHESES;

CHLOROFORM; GUANIDINE; MATRIX METALLOPROTEINASE; MESSENGER RNA; PHENOL; THIOCYANATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN TISSUE; MALE; PROSTHESIS LOOSENING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TOTAL HIP PROSTHESIS;

EID: 0034579064     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-4636(20001215)52:4<613::AID-JBM5>3.0.CO;2-8     Document Type: Article

References (54)

1. 2 production by the membrane surrounding loose and fixated cemented tibial hemiarthroplasties in the rabbit knee
2. A histologic and biochemical comparison of the interface tissues in cementless and cemented hip prostheses
3. Neutral proteinases and their inhibitors in the loosening of total hip prostheses
4. Wear particulate species and bone loss in failed total joint arthroplasties
5. Aseptic loosening of total hip replacement: Macrophage expression of inducible nitric oxide synthase and cyclo-oxygenase-2, together with peroxynitite formation, as a possible mechanism for early prosthesis failure
6. Extracellular matrix metalloproteinases around loose total hip prostheses
7. Gelatinase/type IV collagenases in the loosening of total hip replacement endoprosthesis
8. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in loose artificial hip joints
9. MT1-MMP/MMP-2/TIMP-2 system in the periprosthetic connective tissue remodeling in loose hip prosthesis
10. Activation mechanisms of matrix metalloproteinases
11. Production of matrix metalloproteinases at the bone-implant interface in loose total hip replacements
12. mRNA Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in interface tissue around implants in loosening total hip arthroplasty
13. High levels of expression of collagenase-3 (MMP-13) in pathological conditions associated with a foreign-body reaction
14. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
15. Quantification of mRNA by the polymerase chain reaction
16. Quantification of mRNA by non-radioactive RT-PCR and CCD imaging system
17. Factor(s) present in sera from patients on long-term hemodialysis increase(s) mRNAs for collagenase and stromelysin in synovial cells
18. Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: Different profiles in trauma and RA
19. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in joint fluid of the patients with loose artificial hip joints
20. The collagen substrate specificity of human skin fibroblast collagenase
21. Initiation of osteoclast bone resorption by interstitial collagenase
22. SV40-transformed human lung fibroblast secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages
23. Expression of 92 kD type IV collagenase/gelatinase B in human osteoclasts
24. Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2
25. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules
26. Membrane-type-1 matrix metalloproteinase is abundantly expressed in fibroblasts and osteoclasts at the bone-implant interface of aseptically loosened joint arthroplasties in situ
27. Molecular cloning and expression of collagenase-3, a novel matrix metalloproteinase produced by breast carcinoma
28. Biochemical characterization of human collagenase-3
29. Activation of progelatinase B (proMMP-9) by active collagenase-3 (MMP-13)
30. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metatloprotease capable of degrading basement membrane collagen
31. Cellular mechanisms for human procollagenase-3 (MMP-13) activation: Evidence that MT1-MMP (MMP-14) and gelatinase A (MMP-2) are able to generate active enzyme
32. Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity
33. New collagenolytic enzymes/cascade identified at the pannus-hard tissue junction in rheumatoid arthritis: Destruction from above
34. Expression of gelatinase A and its activator MT1-MMP in the inflammatory periprosthetic response to polyethylene
35. Degradation of proteoglycan aggregate by a cartilage metalloproteinase: Evidence for the involvement of stromelysin in the degradation of link protein heterogeneity in situ
36. Identification of a stromelysin cleavage site within the interglobular domain of human aggrecan: Evidence for proteolysis at the site in vivo in human articular cartilage
37. The collagen substrate specificity of human neutrophil collagenase
38. Chondrocyte matrix metalloproteinase-8: Human articular chondrocytes express neutrophil collagen
39. Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells: Regulation by tumor necrosis factor-alpha and doxycycline
40. The collagenase gene family in humans consists of at least four members
41. Pump-1 cDNA codes for a protein with characteristics similar to those of classical collagenase family members
42. Expression of matrix metalloproteinase 7 (matrilysin) in human osteoarthritic cartilage
43. Novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas
44. Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas, and malignant non-Hodgkin's lymphomas in humans
45. Dual regulation of stromelysin-3 by fibroblast growth factor-2 in murine osteoblasts
46. Identification and characterization of a novel human matrix metalloproteinase with unique structural characteristics, chromosomal location, and tissue distribution
47. Matrix metalloproteinase MMP-19 (RASI-1) is expressed on the surface of activated peripheral blood mononuclear cells and is detected as an autoantigen in rheumatoid arthritis
48. Identification and structural and functional characterization of human enamelysin (MMP-20)
49. Stromelysin-1 (MMP-3) and stromelysin-2 (MMP-10) expression in developing human bone: Potential roles in skeletal development
50. Molecular cloning, chromosomal localization, and bacterial expression of a murine macrophage metalloelastase
51. Macrophage elastase (MMP-12)
52. A matrix metalloproteinase expressed on the surface of invasive tumor cells
53. Intracapsular pressure and loosening of hip prostheses: Preoperative measurements in 18 hips
54. Cytokines in aseptic loosening of total hip replacement